Results 51 to 60 of about 9,150,803 (161)

Outcome of Juvenile Idiopathic Arthritis-Enthesitis related Arthritis. [PDF]

, 2011
INTRODUCTION : Juvenile Idiopathic Arthritis (JIA) is defined as arthritis in one or more joints persisting for 6 weeks or more, which begins before the 16th birthday and has no other known cause.
Saravanan, M
core  

Annual incidence of juvenile idiopathic arthritis (JIA), juvenile rheumatoid arthritis (JRA), enthesitis-related arthritis (ERA), and psoriatic arthritis (PsA) for the period 1999–2009.

, 2013
Annual incidence of juvenile idiopathic arthritis (JIA), juvenile rheumatoid arthritis (JRA), enthesitis-related arthritis (ERA), and psoriatic arthritis (PsA) for the period 1999–2009.
Chang-Ping Lin (441810), Jyh-Hong Lee (441807), Yu-Tsan Lin (441808), Pau-Chung Chen (130563), Li-Chieh Wang (441806), Yao-Hsu Yang (441809), Hsin-Hui Yu (441805), Bor-Luen Chiang (277733)   +7 more
core   +1 more source

Early diagnosis of axial spondyloarthritis is associated with less long‐term spinal structural damage: a longitudinal analysis of the Swiss Clinical Quality Management in rheumatic diseases registry

Arthritis &Rheumatology, Accepted Article.
Objectives The Assessment of SpondyloArthritis international Society recently defined early axial spondyloarthritis (axSpA) as a duration ≤2 years of axial symptoms. Previous studies have shown no significant difference in short‐term outcomes between early and established axSpA patients treated with biologic/targeted synthetic disease‐modifying anti ...
Annik Steimer, Jonas Brändli, Mauro Bachmann, Andrea Götschi, Claudia L. Rodrigues, Michael J. Nissen, Burkhard Möller, Kristina Bürki, Martin Wendiggensen, Simon Grosswiler, Michael Andor, Diana Dan, Frauke Förger, Sabine Adler, Diego Kyburz, Oliver Distler, Raphael Micheroli, Sofia Ramiro, Adrian Ciurea   +18 more
wiley   +1 more source

Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis : pooled analysis of two phase 3 studies [PDF]

, 2019
BACKGROUND: Enthesitis is one of the psoriatic arthritis (PsA) domains. Patients with enthesitis are associated with worse outcomes than those without enthesitis. The effect of secukinumab on the resolution of enthesitis in patients with PsA was explored
Pricop, Luminita, Schett, GA, Schett, Georg A, Rasouliyan, L, Pricop, L, Schett, Georg A., Coates, Laura C.,, Asquith, Darren L., Gaillez, Corine, Coates, LC, Quebe-Fehling, Erhard,, Gaillez, Corine,, Coates, Laura C., McInnes, Iain B.,, McInnes, Iain B., Rasouliyan, Lawrence, Rasouliyan, Lawrence,, Wallman, Johan K.,, Coates, Laura, Mease, Philip, Mease, PJ, Quebe-Fehling, E, Fasth, Andreas E.R.,, Mease, Philip J.,, McGonagle, Dennis, Schett, Georg A.,, Mease, Philip J., Fasth, Andreas E. R., McGonagle, D, McInnes, IB, McGonagle, Dennis,, Fasth, Andreas E.R., Wallman, Johan K., Pricop, Luminita,, Gaillez, C, Asquith, Darren L.,, Asquith, Darren L, Coates, Laura C, McInnes, Iain B, Quebe-Fehling, Erhard, Wallman, Johan K, Fasth, Andreas E R, Lund University., Fasth, AER, Wallman, JK, Asquith, DL   +45 more
core   +1 more source

Juvenile Spondyloarthritis: focus on uveitis

Pediatric Rheumatology Online Journal, 2020
Background Juvenile spondyloarthritis (JSpA) represents a group of inflammatory arthritides with several distinctive features (enthesitis, involvement of spine and sacroiliac joint, HLA-B27 association and development of uveitis).
Achille Marino, Pamela F. Weiss, Timothy G. Brandon, Melissa A. Lerman   +3 more
doaj   +1 more source

Plasma Proteomics Identifies Molecular Signatures and Biomarkers Associated with High Structural Damage in Ankylosing Spondylitis

Arthritis &Rheumatology, Accepted Article.
Objective Pathological bone formation in ankylosing spondylitis (AS) is not fully reflected by systemic inflammation, limiting the utility of inflammatory markers for structural damage assessment. This study aimed to identify plasma protein signatures associated with structural damage severity in AS.
Tiantian Sun, Wanlin Liu, Kun Yang, Xiaohan Xu, Yu Wang, Xinning Qu, Yifan Gong, Wenya Zhang, Jie Ma, Hongxiao Liu   +9 more
wiley   +1 more source

Enthesitis and Dactylitis Resolution with Risankizumab for Active Psoriatic Arthritis: Integrated Analysis of the Randomized KEEPsAKE 1 and 2 Trials

Dermatology and Therapy
Introduction The presence (vs absence) of enthesitis/dactylitis is associated with greater psoriatic arthritis (PsA) activity and reduced health-related quality of life. Risankizumab, an interleukin 23 antagonist, demonstrated superior treatment efficacy
Shawn G. Kwatra, Saakshi Khattri, Ahmad Z. Amin, Roberto Ranza, Blair Kaplan, Linyu Shi, Byron Padilla, Ahmed M. Soliman, Dennis McGonagle   +8 more
doaj   +1 more source

Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

RMD Open
Objective Evaluate long-term guselkumab effectiveness across Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-recognised domains/related conditions of psoriatic arthritis (PsA).Methods Post hoc analyses used data from ...
Laure Gossec, Peter Nash, Philip J Mease, Emmanouil Rampakakis, Laura C Coates, Philip S Helliwell, Alexa P Kollmeier, Xie L Xu, May Shawi, Miriam Zimmermann, Natalie J Shiff   +10 more
doaj   +1 more source

Preliminary Validation of the Early Sacroiliitis Screening Tool (ESHST) for Identifying Hidradenitis Suppurativa Patients at High Risk of Spondyloarthritis

International Journal of Dermatology, EarlyView.
Development and preliminary validation of the Early Sacroiliitis Screening Tool (ESHST), a dermatology‐oriented screening questionnaire for identifying hidradenitis suppurativa patients at increased risk of spondyloarthritis. ABSTRACT Background Hidradenitis suppurativa (HS) is increasingly recognized as a systemic inflammatory disease associated with ...
Umut Bakay, Ozge Sevil Karstarli Bakay, Tugba Izci Duran, Niyazi Cetin   +3 more
wiley   +1 more source

The Effect of PTPN22 Polymorphism on Juvenile Idiopathic Arthritis Subtypes and Disease Activity in a Finnish Study Population

International Journal of Immunogenetics, EarlyView.
ABSTRACT Genetic factors that modulate immune regulation are increasingly recognised as contributors to the heterogeneity and clinical course of autoimmune diseases. Polymorphisms of protein tyrosine phosphatase non‐receptor type 22 (PTPN22) are associated with several autoimmune diseases.
Sonja Kvist, Johanna Teräsjärvi, Heidi Rahikkala, Jussi Mertsola, Milja Möttönen, Qiushui He   +5 more
wiley   +1 more source